104 related articles for article (PubMed ID: 30450675)
1. Characterization of aged rat vocal fold fibroblasts.
Kawai Y; Kishimoto Y; Sogami T; Suzuki R; Tsuji T; Hiwatashi N; Tateya I; Kanemaru SI; Nakamura T; Omori K; Hirano S
Laryngoscope; 2019 Mar; 129(3):E94-E101. PubMed ID: 30450675
[TBL] [Abstract][Full Text] [Related]
2. Cryotherapy has antifibrotic and regenerative effects on human vocal fold fibroblasts.
Gong T; Zhang C; Kang J; Lamb JJ; Jiang JJ
Laryngoscope; 2019 Apr; 129(4):E143-E150. PubMed ID: 30315572
[TBL] [Abstract][Full Text] [Related]
3. HGF and bFGF Secreted by Adipose-Derived Mesenchymal Stem Cells Revert the Fibroblast Phenotype Caused by Vocal Fold Injury in a Rat Model.
Li X; Wang H; Xu W
J Voice; 2022 Sep; 36(5):622-629. PubMed ID: 32921552
[TBL] [Abstract][Full Text] [Related]
4. Modeling fibrosis using fibroblasts isolated from scarred rat vocal folds.
Kishimoto Y; Kishimoto AO; Ye S; Kendziorski C; Welham NV
Lab Invest; 2016 Jul; 96(7):807-16. PubMed ID: 27111284
[TBL] [Abstract][Full Text] [Related]
5. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts.
Suehiro A; Hirano S; Kishimoto Y; Tateya I; Rousseau B; Ito J
Ann Otol Rhinol Laryngol; 2010 Oct; 119(10):690-6. PubMed ID: 21049855
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
[TBL] [Abstract][Full Text] [Related]
7. NR4A1 is an endogenous inhibitor of vocal fold fibrosis.
Hiwatashi N; Bing R; Kraja I; Branski RC
Laryngoscope; 2017 Sep; 127(9):E317-E323. PubMed ID: 28581197
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.
Vyas B; Ishikawa K; Duflo S; Chen X; Thibeault SL
Ann Otol Rhinol Laryngol; 2010 May; 119(5):350-7. PubMed ID: 20524582
[TBL] [Abstract][Full Text] [Related]
9. Vocal fold fibroblast response to growth factor treatment is age dependent: results from an in vitro study.
Graupp M; Kiesler K; Friedrich G; Ainödhofer H; Gruber HJ; Kieslinger P; Saxena A; Hirano S; Gugatschka M
J Voice; 2014 Jul; 28(4):420-3. PubMed ID: 24495429
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of growth factors for aging voice.
Hirano S; Bless DM; del Río AM; Connor NP; Ford CN
Laryngoscope; 2004 Dec; 114(12):2161-7. PubMed ID: 15564837
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms Underlying the Antifibrotic Potential of Estradiol for Vocal Fold Fibrosis.
Ozawa S; Mukudai S; Sugiyama Y; Branski RC; Hirano S
Laryngoscope; 2021 Oct; 131(10):2285-2291. PubMed ID: 33378560
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells have antifibrotic effects on transforming growth factor-β1-stimulated vocal fold fibroblasts.
Hiwatashi N; Bing R; Kraja I; Branski RC
Laryngoscope; 2017 Jan; 127(1):E35-E41. PubMed ID: 27345475
[TBL] [Abstract][Full Text] [Related]
13. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling.
Shinde AV; Humeres C; Frangogiannis NG
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):298-309. PubMed ID: 27825850
[TBL] [Abstract][Full Text] [Related]
14. Dual growth factor-immobilized bioactive injection material for enhanced treatment of glottal insufficiency.
Choi YH; Ahn HJ; Park MR; Han MJ; Lee JH; Kwon SK
Acta Biomater; 2019 Mar; 86():269-279. PubMed ID: 30599245
[TBL] [Abstract][Full Text] [Related]
15. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
Hirano S; Bless D; Heisey D; Ford C
Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
[TBL] [Abstract][Full Text] [Related]
16. Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds.
Ohno T; Yoo MJ; Swanson ER; Hirano S; Ossoff RH; Rousseau B
Ann Otol Rhinol Laryngol; 2009 Aug; 118(8):559-64. PubMed ID: 19746753
[TBL] [Abstract][Full Text] [Related]
17. Cellular source and proinflammatory roles of high-mobility group box 1 in surgically injured rat vocal folds.
Li-Jessen NYK; Powell M; Choi AJ; Lee BJ; Thibeault SL
Laryngoscope; 2017 Jun; 127(6):E193-E200. PubMed ID: 27774594
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility and efficacy of collagen/gelatin sponge scaffold with sustained release of basic fibroblast growth factor on vocal fold fibroblasts in 3-dimensional culture.
Hiwatashi N; Hirano S; Mizuta M; Tateya I; Kanemaru S; Nakamura T; Ito J; Kawai K; Suzuki S
Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):116-25. PubMed ID: 25115594
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human vocal fold fibroblasts derived from chronic scar.
Jetté ME; Hayer SD; Thibeault SL
Laryngoscope; 2013 Mar; 123(3):738-45. PubMed ID: 23444190
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy induces antifibrotic alterations in primary human vocal fold fibroblasts.
Zhang C; Wang J; Chou A; Gong T; Devine EE; Jiang JJ
Laryngoscope; 2018 Sep; 128(9):E323-E331. PubMed ID: 29668038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
